JAGX
Jaguar Animal Health Inc
NASDAQ: JAGX · HEALTHCARE · BIOTECHNOLOGY
$6.96
+2993.33% today
Updated 2026-04-30
Market cap
$3.65M
P/E ratio
—
P/S ratio
0.32x
EPS (TTM)
$-22.97
Dividend yield
—
52W range
$0 – $13
Volume
0.6M
Jaguar Animal Health Inc (JAGX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2007 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-18.37M | $-5.46M | $-14.32M | $-14.41M | $-9.82M | $-22.73M | $-20.46M | $-15.28M | $-34.97M | $-33.10M | $-33.24M | $-29.38M | $5.80M |
| Capital expenditures | $389014.00 | $55149.00 | $23300.00 | $104207.00 | $6527.00 | $6527.00 | $7000.00 | $7000.00 | $6000.00 | $1.68M | $0.00 | $231000.00 | $25000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $164156.00 | $992165.00 | $717927.00 | $814613.00 | $2.02M | $2.99M | $2.82M | $3.97M | $3.32M | $2.11M | $1.64M | $-810000.00 |
| Free cash flow | $-18.76M | $-5.52M | $-14.34M | $-14.52M | $-9.83M | $-22.74M | $-20.46M | $-15.29M | $-34.98M | $-34.78M | $-33.24M | $-29.61M | $5.77M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | $0.00 | $0.00 | $12.24M | — | $33000.00 | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $6.85M | $-6.75M | $-430281.00 | $1.81M | $1.32M | $4.21M | — | — | — | — | — |